STOCK TITAN

Institutional Investor Fuller & Thaler Reports 1.74M CNMD Shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Fuller & Thaler Asset Management, Inc. filed a Schedule 13G reporting beneficial ownership of 1,740,630.07 shares of Conmed Corp common stock, representing 5.63% of the class. The filer reports sole voting power for 1,714,377.07 shares and sole dispositive power for 1,740,630.07 shares, with no shared voting or dispositive power disclosed.

The filing states these securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. Fuller & Thaler acts as investment adviser to the underlying accounts that own the shares.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: An investment adviser reports a >5% passive stake in Conmed, signaling a notable institutional position without control intent.

This Schedule 13G shows Fuller & Thaler holds 5.63% of Conmed common stock with substantial sole voting and dispositive power, indicating direct portfolio control rather than pooled or shared authority. The filer certifies holdings are in the ordinary course and not aimed at influencing control, which is consistent with passive investor behavior under Rule 13d-1(b). For investors, a >5% disclosure is material because it reveals concentrated institutional ownership that could affect liquidity and shareholder base composition.

TL;DR: Disclosure appears complete for a 13G: holder details, ownership percentages, and certification are provided.

The filing includes issuer and filer addresses, CUSIP, exact share counts, percent of class, and a certification that the position is held in the ordinary course, which meets Schedule 13G disclosure standards. No group affiliation or subsidiaries are reported, and the filing date and signature are present. There are no indications of withheld or ambiguous voting/dispositive arrangements in the text provided.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Fuller & Thaler Asset Management, Inc.
Signature:Hanna Zanoni
Name/Title:Hanna Zanoni,Chief Compliance Officer
Date:08/14/2025